Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Bioavailability of COV155 in Healthy Subjects
NCT02561650Phase 1Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Dec 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of hydrocodone and acetaminophen in acute pain, osteoarthritis (OA) and chronic low back pain (CLBP), sponsored by Mallinckrodt Pharmaceuticals. Primary endpoints: Area under the plasma concentration-time curve at 48 hours, Maximum observed plasma concentration at 48 hours and 1 more. Started Dec 2011; status: completed.
02
Drugs
hydrocodoneacetaminophen
03
Conditions
acute painosteoarthritis (OA)chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT02561650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02561650.